MedCity News November 7, 2025
The six new drugs awarded FDA Commissioner’s National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to “within months.”
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program open to products addressing certain national health priorities.
Rare and infectious diseases as well as cancer are the other therapeutic areas covered by the new batch of voucher recipients. The vouchers announced Thursday come three weeks after the FDA unveiled the first nine drugs selected for this Commissioner’s National Priority Voucher (CNPV) program. Eligible products must...
Today's Sponsors
Today's Sponsor